Jacques Bompart

487 total citations
25 papers, 425 citations indexed

About

Jacques Bompart is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Jacques Bompart has authored 25 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 7 papers in Molecular Biology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Jacques Bompart's work include Synthesis and Biological Evaluation (11 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers) and Synthesis and biological activity (4 papers). Jacques Bompart is often cited by papers focused on Synthesis and Biological Evaluation (11 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers) and Synthesis and biological activity (4 papers). Jacques Bompart collaborates with scholars based in France, Jordan and United Kingdom. Jacques Bompart's co-authors include Michèle Calas, Henri Vial, Marie‐Laure Ancelin, L. Giral, Pierre‐Antoine Bonnet, Pierre Druilhe, Dominique Martin, Guy Subra, Carine Deleuze‐Masquéfa and E Despaux and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Jacques Bompart

24 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques Bompart France 11 243 141 137 51 30 25 425
Sophie Girault France 8 202 0.8× 111 0.8× 149 1.1× 40 0.8× 30 1.0× 8 337
Shuren Zhu United States 10 327 1.3× 193 1.4× 64 0.5× 29 0.6× 25 0.8× 11 461
Rishi Kumar India 16 398 1.6× 212 1.5× 109 0.8× 34 0.7× 23 0.8× 28 557
Hardwin O’Dowd United States 13 277 1.1× 151 1.1× 167 1.2× 97 1.9× 65 2.2× 19 467
Suryanarayana Vangapandu India 8 239 1.0× 211 1.5× 90 0.7× 34 0.7× 53 1.8× 10 437
Neira Gamboa Venezuela 15 435 1.8× 211 1.5× 125 0.9× 61 1.2× 35 1.2× 34 603
Ik‐Hyeon Paik United States 7 173 0.7× 110 0.8× 200 1.5× 93 1.8× 71 2.4× 7 396
José M. Bueno Spain 11 205 0.8× 118 0.8× 134 1.0× 86 1.7× 58 1.9× 16 410
Maria Alvim‐Gaston United States 7 123 0.5× 81 0.6× 113 0.8× 80 1.6× 20 0.7× 10 265
Kuldeep Chauhan India 10 454 1.9× 150 1.1× 101 0.7× 48 0.9× 33 1.1× 13 559

Countries citing papers authored by Jacques Bompart

Since Specialization
Citations

This map shows the geographic impact of Jacques Bompart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Bompart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Bompart more than expected).

Fields of papers citing papers by Jacques Bompart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Bompart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Bompart. The network helps show where Jacques Bompart may publish in the future.

Co-authorship network of co-authors of Jacques Bompart

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Bompart. A scholar is included among the top collaborators of Jacques Bompart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Bompart. Jacques Bompart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khier, Sonia, Florence Gattacceca, Safia El Messaoudi, et al.. (2010). Metabolism and Pharmacokinetics of EAPB0203 and EAPB0503, Two Imidazoquinoxaline Compounds Previously Shown to Have Antitumoral Activity on Melanoma and T-Lymphomas. Drug Metabolism and Disposition. 38(10). 1836–1847. 12 indexed citations
2.
Deleuze‐Masquéfa, Carine, et al.. (2006). Impairment of TNF-α Production and Action by Imidazo[1,2- α] Quinoxalines, as Derivative Family Which Displays Potential Anti-Inflammatory Properties. International Journal of Immunopathology and Pharmacology. 19(3). 525–538. 11 indexed citations
3.
Deleuze‐Masquéfa, Carine, Grégori Gerebtzoff, Guy Subra, et al.. (2004). Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors. Bioorganic & Medicinal Chemistry. 12(5). 1129–1139. 27 indexed citations
4.
Escale, Roger, et al.. (2000). Solution Parallel Synthesis of Cyclic Guanidines. Heterocycles. 53(6). 1317–1317. 4 indexed citations
5.
Pocock, Tristan, Keith Elliott, Guy Subra, et al.. (1999). New imidazo[1,2-a]pyrazine derivatives with bronchodilatory and cyclic nucleotide phosphodiesterase inhibitory activities. Bioorganic & Medicinal Chemistry. 7(6). 1059–1065. 24 indexed citations
6.
El‐Abadelah, Mustafa M., et al.. (1998). Thienopyridinone antibacterials: Synthesis and antibacterial activity of some 7-aryl-2-chloro-4,7-dihydro-4-oxothieno[2,3-b]pyridine-5-carboxylic acids. European Journal of Medicinal Chemistry. 33(1). 33–42. 19 indexed citations
7.
Bonnet, Pierre‐Antoine, Guy Subra, Jean‐Roch Fabreguettes, et al.. (1998). [SCA 40 and derivatives: new bronchodilators in an imidazo(1,2-a)pyrazine series].. PubMed. 56(4). 155–9. 1 indexed citations
8.
El‐Abadelah, Mustafa M., et al.. (1998). Thienopyridinone Antibacterials. Part II.1 Synthesis and Antibacterial Activity of Some 2-Chloro-7-Cyclopropyl-4,7-Dihydro-4-Oxothieno [2,3-b]Pyridine-5-Carboxylic Acids. Phosphorus, sulfur, and silicon and the related elements. 134(1). 21–29. 10 indexed citations
9.
10.
Ancelin, Marie‐Laure, Michèle Calas, Jacques Bompart, et al.. (1998). Antimalarial Activity of 77 Phospholipid Polar Head Analogs: Close Correlation Between Inhibition of Phospholipid Metabolism and In Vitro Plasmodium Falciparum Growth. Blood. 91(4). 1426–1437. 90 indexed citations
11.
Lafitte, Daniel, Jacques Bompart, F Laurent, et al.. (1997). Characterization of Low Affinity Complexes Between Calmodulin and Pyrazine Derivatives by Electrospray Ionization Mass Spectrometry. Journal of Mass Spectrometry. 32(1). 87–93. 6 indexed citations
12.
Bonnet, Pierre‐Antoine, et al.. (1997). Nitration in the imidazo[1,2‐a]pyrazine series. Experimental and computational results. Journal of Heterocyclic Chemistry. 34(3). 701–707. 5 indexed citations
13.
Bompart, Jacques, et al.. (1997). Interest of cluster significance analysis in structure-affinity relationships for non-xanthine heterocyclic antagonists of adenosine. European Journal of Medicinal Chemistry. 32(6). 493–504. 1 indexed citations
14.
Grassy, Gérard, et al.. (1995). Variable mapping of structure-activity relationships: Application to 17-spirolactone derivatives with mineralocorticoid activity. Journal of Molecular Graphics. 13(6). 356–367. 6 indexed citations
15.
Michel, A., F Laurent, Jacques Bompart, et al.. (1993). Cardiovascular effects of SCA40, a novel potassium channel opener, in rats. British Journal of Pharmacology. 110(3). 1031–1036. 13 indexed citations
16.
Laurent, F, et al.. (1993). [Effects of toxins, apamine, charybdotoxin and iberiotoxin on the relaxation of the smooth muscular fiber induced by imidazo(1,2-a)pyrazine derivative].. PubMed. 187(4). 526–35. 2 indexed citations
17.
Calas, Michèle, Jacques Bompart, L. Giral, & Gérard Grassy. (1991). Relation structure—activité dans la série des quinolones. European Journal of Medicinal Chemistry. 26(3). 279–290. 6 indexed citations
18.
Bompart, Jacques, et al.. (1991). Synthèse et activité anti-bactérienne d'acides 4,7-dihydro-4-éthyl-7-oxothiéno(3,2-b)pyridine-6-carboxyliques. European Journal of Medicinal Chemistry. 26(1). 3–11. 25 indexed citations
19.
20.
Bompart, Jacques. (1988). Synthèse et activité anti-bactérienne d'acides dihydro-4,7 éthyl-7 oxo-4 thiéno[2,3-b]pyridine carboxyliques-5 II. European Journal of Medicinal Chemistry. 23(5). 457–464. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sophie Girault Breakdown of academic impact, for papers by Shuren Zhu Breakdown of academic impact, for papers by Rishi Kumar Breakdown of academic impact, for papers by Hardwin O’Dowd Breakdown of academic impact, for papers by Suryanarayana Vangapandu Breakdown of academic impact, for papers by Neira Gamboa Breakdown of academic impact, for papers by Ik‐Hyeon Paik Breakdown of academic impact, for papers by José M. Bueno Breakdown of academic impact, for papers by Maria Alvim‐Gaston Breakdown of academic impact, for papers by Kuldeep Chauhan
Rankless by CCL
2026